Literature DB >> 30037721

Premature mortality projections in the USA through 2030: a modelling study.

Ana F Best1, Emily A Haozous2, Amy Berrington de Gonzalez3, Pavel Chernyavskiy3, Neal D Freedman3, Patricia Hartge3, David Thomas4, Philip S Rosenberg3, Meredith S Shiels3.   

Abstract

BACKGROUND: Although life expectancy has been projected to increase across high-income countries, gains for the USA are anticipated to be among the smallest, and overall US death rates actually increased from 2014 to 2015, with divergence for specific US populations. Therefore, projecting future premature mortality is essential for clinical and public health service planning, curbing rapidly increasing causes of death, and sustaining progress in declining causes of death. We aimed to project premature mortality (here defined as deaths of individuals aged 25-64 years) trends through 2030, and to estimate the total number of projected deaths, the projected number of potential years of life lost due to premature mortality, and the effect of reducing projected accidental death rates by 2% per year.
METHODS: We obtained death certificate data for the US population aged 25-64 years for 1990-2015 from the US Centers for Disease Control and Prevention (CDC) National Center for Health Statistics. We obtained US mortality data for 2016 for non-American Indian or Alaska native groups from CDC WONDER; data for 2016 were not available for American Indians or Alaska natives. Our analysis focused on all-cause premature mortality and the commonest causes of premature death (cancer, heart disease, accidents, suicide, and chronic liver disease or cirrhosis) among white, black, Hispanic, Asian or Pacific islanders, and American Indian or Alaska native men and women. We estimated age-standardised premature mortality and corresponding annual percentage changes for 2017-30 by sex and race or ethnic origin by use of age-period-cohort forecasting models. We also did a sensitivity analysis projecting future mortality from cross-sectional mortality and a JoinPoint of the (log) period rate ratio curve. We calculated absolute death counts by use of corresponding age-specific and year-specific US census population projections, and estimated years of potential life lost.
FINDINGS: During 2017-30, all-cause deaths are projected to increase among white women and American Indians or Alaska natives, resulting in 239 700 excess premature deaths relative to 2017 rates (a 10% increase). Mortality declines in white men and black, Hispanic, and Asian or Pacific islander men and women will result in 945 900 fewer deaths (a 14% reduction). Cancer mortality rates are projected to decline among white, black, Hispanic, and Asian or Pacific islander women and men, with the largest declines among black women (age-standardised premature mortality rate 2016: 104·5 deaths per 100 000 woman-years; 2030: 77·1 per 100 000 woman-years) and men (2016: 116·8 per 100 000 man-years; 2030: 81·6 per 100 000 man-years). Heart disease death rates are projected to increase in American Indian or Alaska native men (2015: 150·9 per 100 000 man-years; 2030: 175·9 per 100 000 man-years) and decline in other groups, albeit only slightly in white (2016: 35·6 per 100 000 woman-years; 2030: 31·1 per 100 000 woman-years) and American Indian or Alaska native women (2015: 64·4 per 100 000 woman-years; 2030: 62·8 per 100 000 woman-years). Accidental death rates are projected to increase in all US populations except Asian or Pacific islander women, and will increase most rapidly among white women (2030: 60·5 per 100 000 woman-years) and men (2030: 101·9 per 100 000 man-years) and American Indian or Alaska native women (2030: 97·5 per 100 000 woman-years) and men (2030: 298·7 per 100 000 man-years). Suicide rates are projected to increase for all groups, and chronic liver disease and cirrhosis deaths are projected to increase for all groups except black men. A 2% per year reduction in projected accidental deaths would eliminate an estimated 178 700 deaths during 2017-30.
INTERPRETATION: To reduce future premature mortality, effective interventions are needed to address rapidly rising mortality rates due to accidents, suicides, and chronic liver disease and cirrhosis. FUNDING: National Cancer Institute Intramural Research Program.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30037721      PMCID: PMC6233712          DOI: 10.1016/S2468-2667(18)30114-2

Source DB:  PubMed          Journal:  Lancet Public Health


  35 in total

1.  Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area.

Authors:  Melissa A Jim; Elizabeth Arias; Dean S Seneca; Megan J Hoopes; Cheyenne C Jim; Norman J Johnson; Charles L Wiggins
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

2.  Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013.

Authors:  Beth Han; Wilson M Compton; Christopher M Jones; Rong Cai
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

3.  Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Silvia S Martins; Aaron Sarvet; Julian Santaella-Tenorio; Tulshi Saha; Bridget F Grant; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

4.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Authors:  Anne Case; Angus Deaton
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Productivity costs of cancer mortality in the United States: 2000-2020.

Authors:  Cathy J Bradley; K Robin Yabroff; Bassam Dahman; Eric J Feuer; Angela Mariotto; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2008-12-09       Impact factor: 13.506

6.  Racial and geographic variation in coronary heart disease mortality trends.

Authors:  Richard F Gillum; Alem Mehari; Bryan Curry; Thomas O Obisesan
Journal:  BMC Public Health       Date:  2012-06-06       Impact factor: 3.295

7.  Cause of death affects racial classification on death certificates.

Authors:  Andrew Noymer; Andrew M Penner; Aliya Saperstein
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

8.  Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020.

Authors:  Hannah K Weir; Robert N Anderson; Sallyann M Coleman King; Ashwini Soman; Trevor D Thompson; Yuling Hong; Bjorn Moller; Steven Leadbetter
Journal:  Prev Chronic Dis       Date:  2016-11-17       Impact factor: 2.830

9.  Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing Patterns and Widening Inequalities.

Authors:  Gopal K Singh; Ahmedin Jemal
Journal:  J Environ Public Health       Date:  2017-03-20

10.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

View more
  18 in total

1.  Is surgical volume still the most accurate indicator of blood usage in the United States?

Authors:  Alexandra Savinkina; Mathew R P Sapiano; James Berger; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2019-02-10       Impact factor: 3.157

2.  Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals.

Authors:  Joseph E Tota; Ana F Best; Zachary S Zumsteg; Maura L Gillison; Philip S Rosenberg; Anil K Chaturvedi
Journal:  J Clin Oncol       Date:  2019-04-26       Impact factor: 44.544

3.  Response to DeSantis and Jemal.

Authors:  Brittny C Davis Lynn; Philip S Rosenberg; William F Anderson; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

4.  Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018.

Authors:  Young-Hee Yoon; Chiung M Chen; Megan E Slater; M Katherine Jung; Aaron M White
Journal:  Am J Prev Med       Date:  2020-08-27       Impact factor: 5.043

5.  Momentum and Longevity for Tribally Driven Health Equity Science: Evidence from the Gathering for Health Project.

Authors:  Jessica H L Elm; Tina Handeland
Journal:  Hum Biol       Date:  2020-07-09       Impact factor: 0.553

6.  Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder.

Authors:  Hilary S Connery; Nadine Taghian; Jungjin Kim; Margaret Griffin; Ian R H Rockett; Roger D Weiss; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-10-05       Impact factor: 4.492

7.  Spatially varying age-period-cohort analysis with application to US mortality, 2002-2016.

Authors:  Pavel Chernyavskiy; Mark P Little; Philip S Rosenberg
Journal:  Biostatistics       Date:  2020-10-01       Impact factor: 5.899

8.  The effect of average temperature on suicide rates in five urban California counties, 1999-⁠2019: an ecological time series analysis.

Authors:  Sierra Cheng; Rebecca Plouffe; Stephanie M Nanos; Mavra Qamar; David N Fisman; Jean-Paul R Soucy
Journal:  BMC Public Health       Date:  2021-05-25       Impact factor: 3.295

9.  Incidence of Benign Meningiomas in the United States: Current and Future Trends.

Authors:  Sonia Bhala; Douglas R Stewart; Victoria Kennerley; Valentina I Petkov; Philip S Rosenberg; Ana F Best
Journal:  JNCI Cancer Spectr       Date:  2021-04-08

10.  Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.

Authors:  Archita P Desai; Marion Greene; Lauren D Nephew; Eric S Orman; Marwan Ghabril; Naga Chalasani; Nir Menachemi
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.